66774-71-8

Basic information

• Product Name: Benzoic acid 7a-methyl-1-(1-methyl-2-oxo-ethyl)-octahydro-inden-4-yl ester
• Synonyms: Benzoic acid 7a-methyl-1-(1-methyl-2-oxo-ethyl)-octahydro-inden-4-yl ester;(1R,3aR,4S,7aR)-7a-Methyl-1-((S)-1-oxopropan-2-yl)octahydro-1H-inden-4-yl benzoate;[(1R,3aR,4S,7aR)-7a-methyl-1-[(2S)-1-oxopropan-2-yl]-1,2,3,3a,4,5,6,7-octahydroinden-4-yl] benzoate;Benzoic acid 7R-methyl-1-(1S-methyl-2-oxo-ethyl)-octahydro-inden-4S-yl ester
• CAS NO: 66774-71-8
• Molecular Formula: C₂₀H₂₆O₃
• Molecular Weight: 314.42
• Mol File: 66774-71-8.mol
• Article Data: 20

Chemical Properties

• Boiling Point: 422.365°C at 760 mmHg
• Flash Point: 183.17°C
• Appearance: /
• Density: 1.104g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.542
• CAS DataBase Reference: Benzoic acid 7a-methyl-1-(1-methyl-2-oxo-ethyl)-octahydro-inden-4-yl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid 7a-methyl-1-(1-methyl-2-oxo-ethyl)-octahydro-inden-4-yl ester(66774-71-8)
• EPA Substance Registry System: Benzoic acid 7a-methyl-1-(1-methyl-2-oxo-ethyl)-octahydro-inden-4-yl ester(66774-71-8)

Safety Data

• Hazardous Substances Data: 66774-71-8(Hazardous Substances Data)

Usage

InChI:InChI=1/C20H26O3/c1-14(13-21)16-10-11-17-18(9-6-12-20(16,17)2)23-19(22)15-7-4-3-5-8-15/h3-5,7-8,13-14,16-18H,6,9-12H2,1-2H3/t14-,16?,17?,18+,20-/m1/s1

Upstream product

• 66774-70-7 (8S,20S)-des-A,B-8-benzoyloxy-20-(hydroxymethyl)-pregnane 
• 68702-86-3 Benzoic acid (1R,3aR,7aR)-7a-methyl-1-((E)-(1R,4R)-1,4,5-trimethyl-hex-2-enyl)-octahydro-inden-4-yl ester 
• 98-88-4 benzoyl chloride 
• 55812-82-3 (1R,3aR,7aR)-7a-Methyl-1-((E)-(1R,4R)-1,4,5-trimethyl-hex-2-enyl)-octahydro-inden-4-ol 
• 66774-71-8 Benzoic acid (1R,3aR,7aR)-7a-methyl-1-((S)-1-methyl-2-oxo-ethyl)-octahydro-inden-4-yl ester 
• 66774-80-9 (S)-2-((3R,3aR,7S,7aR)-octahydro-7-hydroxy-3a-methyl-1H-inden-3-yl)propyl 4-methylbenzenesulfonate 
• 55812-82-3 (1R,3aR,4S,7aR)-7a-methyl-1-<(2E)-(1R,4R)-1,4,5-trimethyl-hex-2-enyl>-octahydro-1H-inden-4-ol 
• 50-14-6 Calciferol 
• 64190-52-9 (8S,20S)-de-A,B-20-(hydroxymethyl)pregnan-8-ol 
• 64190-53-0 (S)-2-((1R,3aR,4S,7aR)-4-(benzoyloxy)-7a-methyloctahydro-1H-inden-1-yl)propyl benzoate 
• 68702-86-3 (24R,22E)-des-A,B-8β-(benzoyloxy)ergost-22-ene 
• 100858-19-3 de-A,B-8β-(benzoyloxy)-23,24-dinor-22-(tosyloxy)cholane 

Downstream Products

• 145354-29-6 (20S)-des-A,B-8β-(benzoyloxy)-20-<(2'R,6'R)-6'-methyl-4'-oxo-1',3'-dioxan-2'-yl>pregnane 
• 142700-23-0 (22S)-25-<(tert-butyldimethylsilyl)oxy>-22-hydroxy-de-A,B-cholest-23-yn-8β-yl benzoate 
• 142700-23-0 (22R)-25-<(tert-butyldimethylsilyl)oxy>-22-hydroxy-de-A,B-cholest-23-yn-8β-yl benzoate 
• 66774-70-7 (8S,20S)-des-A,B-8-benzoyloxy-20-(hydroxymethyl)-pregnane 
• 145354-28-5 (20R)-des-A,B-8β-(benzoyloxy)-23,24-dinorcholane-22-ol 
• 66774-71-8 Benzoic acid (1R,3aR,7aR)-7a-methyl-1-((R)-1-methyl-2-oxo-ethyl)-octahydro-inden-4-yl ester 
• 437609-71-7 Benzoic acid (1R,3aR,4S,7aR)-1-((S)-2-hydroxy-1,5-dimethyl-5-triethylsilanyloxy-hex-3-ynyl)-7a-methyl-octahydro-inden-4-yl ester 
• 952288-59-4 benzoic acid (1R,3aR,4S,7aR)-7a-methyl-1-[(R)-1'-methylprop-2'-enyl]octahydro-inden-4-yl ester 
• 951777-99-4 (Z)-benzoic acid (1R,3aR,4S,7aR)-1-[(S)-(2'-hydroxyimino-1'-methyl)ethyl]-7a-methyl-octahydro-inden-4-yl ester 
• 951777-98-3 (E)-benzoic acid (1R,3aR,4S,7aR)-1-[(S)-(2'-hydroxyimino-1'-methyl)ethyl]-7a-methyl-octahydro-inden-4-yl ester 
• 1283571-16-3 (8S,20S)-des-A,B-8-benzoyloxy-20-[4'-hydroxy-4'-methylpent-(1'E)-en-yl]-pregnane 
• 1283571-18-5 (8S,20S)-des-A,B-8-benzoyloxy-20-[4'-(tertbutyldimethylsilyloxy)-4'-methyl-pent-(1'E)-en-yl]-pregnane 
• 1016232-58-8 (8S,20S)-des-A,B-8-benzoyloxy-20-[(4'S)-(tertbutyldimethylsilyl)oxy-pent-(1'E)-en-yl]-pregnane 

Relevant articles and documents

2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses

This invention discloses 2α-methyl and 2β-methyl analogs of 19,26-dinor-1α,25-dihydroxyvitamin D3 and pharmaceutical uses therefor. These compounds exhibit in vitro biological activities evidencing use as an anti-cancer agent and for the treatm

2-METHYLENE-19,26-NOR-(20S)-1α-HYDROXYVITAMIN D3

Compounds of formula I are provided where X1 and X2 are independently selected from H or hydroxy protecting groups. Such compounds may be used in preparing pharmaceutical compositions and are useful in treating a variety of biologica

2-Methylene-19,26-Dinor-(20R,22E,25R)-Vitamin D Analogs

This invention discloses 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs, and specifically 2-methylene-19,26-dinor-(20R,22E,25R)-1α,25-dihydroxyvitamin D3, and pharmaceutical uses therefor. This compound exhibits transcription activity